News | August 05, 2021
Dr. Reddy's Laboratories signs asset purchase agreement with BioDelivery Sciences
Dr.Reddy's will receive U.S. $6 million upfront upon closing followed by U.S. $9 million one year from closing
Dr.Reddy's will receive U.S. $6 million upfront upon closing followed by U.S. $9 million one year from closing
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
Nureca Ltd has reported financial results for the period ended June 30, 2021.
Complementary business models are the reason for the acquisition
This deal makes Meddo, one of the largest health-tech players in India
As per the agreement, Lonza will provide commercial-scale manufacture of monoclonal antibodies
The company has predominantly built a portfolio into veterinary products
In an exclusive interview with Rahul Koul of Indian Chemical News, Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals Inc. USA shared details about the company's performance, R&D initiatives, Capex plan, CSR, and future outlook. Excerpts of the interview:
The COVID Working Group has recommended extension of the gap between the first and second doses of Covishield
Port chairpersons have been asked to personally supervise logistic operations to ensure unhindered movement of such consignments for berthing of such vessel on top priority in the port
Subscribe To Our Newsletter & Stay Updated
